+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cell Line Development"

Biosimilar Monoclonal Antibodies Market Report 2022-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market Report 2022-2032

  • Report
  • July 2022
  • 461 Pages
  • Global
From
Global Cell Line Development Market Outlook 2031 - Product Thumbnail Image

Global Cell Line Development Market Outlook 2031

  • Report
  • September 2022
  • 240 Pages
  • Global
From
From
Cell Line Development Market 2024-2028 - Product Thumbnail Image

Cell Line Development Market 2024-2028

  • Report
  • March 2024
  • 163 Pages
  • Global
From
From
From
From
From
UAE Pharmaceutical CDMO Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

UAE Pharmaceutical CDMO Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • January 2025
  • 82 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
Loading Indicator

The Cell Line Development market is a subset of the biotechnology industry that focuses on the development of cell lines for use in research and drug discovery. Cell lines are immortalized cell cultures that can be used to study the effects of drugs, toxins, and other compounds on cells. Cell lines are also used to produce biopharmaceuticals, such as monoclonal antibodies, vaccines, and gene therapies. Cell line development involves the selection, characterization, and optimization of cell lines for specific applications. This process includes the selection of the appropriate cell type, the optimization of culture conditions, and the characterization of the cell line for its suitability for the intended application. Companies in the Cell Line Development market include Thermo Fisher Scientific, Merck KGaA, Lonza, Sartorius AG, Corning Incorporated, and Charles River Laboratories. Show Less Read more